These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 12784402

  • 1. Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course.
    Liozon E, Boutros-Toni F, Ly K, Loustaud-Ratti V, Soria P, Vidal E.
    J Rheumatol; 2003 Jun; 30(6):1272-6. PubMed ID: 12784402
    [Abstract] [Full Text] [Related]

  • 2. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.
    Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M.
    Arthritis Rheum; 2004 Apr; 50(4):1332-7. PubMed ID: 15077317
    [Abstract] [Full Text] [Related]

  • 3. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis.
    Cid MC, Font C, Oristrell J, de la Sierra A, Coll-Vinent B, López-Soto A, Vilaseca J, Urbano-Márquez A, Grau JM.
    Arthritis Rheum; 1998 Jan; 41(1):26-32. PubMed ID: 9433866
    [Abstract] [Full Text] [Related]

  • 4. Silent versus cranial giant cell arteritis. Initial presentation and outcome of 50 biopsy-proven cases.
    Hamidou MA, Batard E, Trewick D, Masseau A, Moreau A, Agard C, Ponge T, Grolleau JY, Barrier J.
    Eur J Intern Med; 2005 Jun; 16(3):183-186. PubMed ID: 15967333
    [Abstract] [Full Text] [Related]

  • 5. [The bane of giant cell arteritis from an ophthalmological viewpoint].
    Meli B, Landau K, Gloor BP.
    Schweiz Med Wochenschr; 1996 Oct 26; 126(43):1821-8. PubMed ID: 9005521
    [Abstract] [Full Text] [Related]

  • 6. Fever in biopsy-proven giant cell arteritis: clinical implications in a defined population.
    Gonzalez-Gay MA, Garcia-Porrua C, Amor-Dorado JC, Llorca J.
    Arthritis Rheum; 2004 Aug 15; 51(4):652-5. PubMed ID: 15334440
    [Abstract] [Full Text] [Related]

  • 7. Concurrent temporal (giant cell) arteritis and malignancy: report of 20 patients with review of the literature.
    Liozon E, Loustaud V, Fauchais AL, Soria P, Ly K, Ouattara B, Rhaiem K, Nadalon S, Vidal E.
    J Rheumatol; 2006 Aug 15; 33(8):1606-14. PubMed ID: 16832846
    [Abstract] [Full Text] [Related]

  • 8. Poor prognosis of visual outcome after visual loss from giant cell arteritis.
    Danesh-Meyer H, Savino PJ, Gamble GG.
    Ophthalmology; 2005 Jun 15; 112(6):1098-103. PubMed ID: 15885780
    [Abstract] [Full Text] [Related]

  • 9. Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis.
    Bahlas S, Ramos-Remus C, Davis P.
    J Rheumatol; 1998 Jan 15; 25(1):99-104. PubMed ID: 9458211
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Influence of age, sex, and place of residence on clinical expression of giant cell arteritis in northwest Spain.
    Gonzalez-Gay MA, Garcia-Porrua C, Amor-Dorado JC, Llorca J.
    J Rheumatol; 2003 Jul 15; 30(7):1548-51. PubMed ID: 12858456
    [Abstract] [Full Text] [Related]

  • 15. Masked giant cell arteritis.
    Cheung PP, Richards G.
    Aust Fam Physician; 2006 Nov 15; 35(11):893-5. PubMed ID: 17099811
    [Abstract] [Full Text] [Related]

  • 16. A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients.
    Chevalet P, Barrier JH, Pottier P, Magadur-Joly G, Pottier MA, Hamidou M, Planchon B, El Kouri D, Connan L, Dupond JL, De Wazieres B, Dien G, Duhamel E, Grosbois B, Jego P, Le Strat A, Capdeville J, Letellier P, Agron L.
    J Rheumatol; 2000 Jun 15; 27(6):1484-91. PubMed ID: 10852275
    [Abstract] [Full Text] [Related]

  • 17. Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity.
    Weyand CM, Fulbright JW, Hunder GG, Evans JM, Goronzy JJ.
    Arthritis Rheum; 2000 May 15; 43(5):1041-8. PubMed ID: 10817557
    [Abstract] [Full Text] [Related]

  • 18. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment.
    González-Gay MA, Blanco R, Rodríguez-Valverde V, Martínez-Taboada VM, Delgado-Rodriguez M, Figueroa M, Uriarte E.
    Arthritis Rheum; 1998 Aug 15; 41(8):1497-504. PubMed ID: 9704651
    [Abstract] [Full Text] [Related]

  • 19. Giant cell arteritis without clinically evident vascular involvement in a defined population.
    Gonzalez-Gay MA, Garcia-Porrua C, Amor-Dorado JC, Llorca J.
    Arthritis Rheum; 2004 Apr 15; 51(2):274-7. PubMed ID: 15077272
    [Abstract] [Full Text] [Related]

  • 20. Giant cell arteritis: diagnosing and treating inflammatory disease in older adults.
    Azhar SS, Tang RA, Dorotheo EU.
    Geriatrics; 2005 Aug 15; 60(8):26-30. PubMed ID: 16092890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.